Literature DB >> 1786070

How do peptides associate with MHC class I molecules?

T Elliott1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1786070     DOI： 10.1016/0167-5699(91)90134-f

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  8 in total

Review 1.  Peptide binding to MHC class I molecules: implications for antigenic peptide prediction.

Authors:  K C Parker; M Shields; M DiBrino; A Brooks; J E Coligan
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

2.  Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis.

Authors:  R O Burney; K D Pile; K Gibson; A Calin; L G Kennedy; P J Sinnott; S H Powis; B P Wordsworth
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

Review 3.  The pathogenesis of HLA-B27 associated arthritis: lessons from the B27 crystal.

Authors:  H Kellner; D Yu
Journal:  Clin Investig       Date:  1994-03

4.  Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice.

Authors:  E E Hamilton-Williams; D V Serreze; B Charlton; E A Johnson; M P Marron; A Mullbacher; R M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 5.  The pathogenetic aspects of spondyloarthropathies from the point of view of HLA-B27.

Authors:  H Kellner; D Yu
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

6.  A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity.

Authors:  M G Mage; L Lee; R K Ribaudo; M Corr; S Kozlowski; L McHugh; D H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules.

Authors:  A Martayan; R Fraioli; E Giorda; A Setini; G Ciccarelli; L Delfino; G B Ferrara; P Giacomini
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene.

Authors:  L Franksson; E George; S Powis; G Butcher; J Howard; K Kärre
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.